Cargando…

Neoadjuvant and adjuvant treatment strategies for hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is the most common liver malignancy worldwide and a major cause of cancer-related mortality for which liver resection is an important curative-intent treatment option. However, many patients present with advanced disease and with underlying chronic liver disease and/or...

Descripción completa

Detalles Bibliográficos
Autores principales:	Akateh, Clifford, Black, Sylvester M, Conteh, Lanla, Miller, Eric D, Noonan, Anne, Elliott, Eric, Pawlik, Timothy M, Tsung, Allan, Cloyd, Jordan M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676544/ https://www.ncbi.nlm.nih.gov/pubmed/31391767 http://dx.doi.org/10.3748/wjg.v25.i28.3704

Ejemplares similares

Neoadjuvant treatment strategies for intrahepatic cholangiocarcinoma
por: Akateh, Clifford, et al.
Publicado: (2020)

National Trends in the Use of Neoadjuvant Therapy Before Cancer Surgery in the US From 2004 to 2016
por: Aquina, Christopher T., et al.
Publicado: (2021)

Neoadjuvant chemotherapy for colorectal liver metastases: A contemporary review of the literature
por: Guo, Marissa, et al.
Publicado: (2021)

Women receive more inpatient resections and ablations for hepatocellular carcinoma than men
por: Sobotka, Lindsay, et al.
Publicado: (2017)

Normothermic Ex-vivo Liver Perfusion and the Clinical Implications for Liver Transplantation
por: Akateh, Clifford, et al.
Publicado: (2018)

Neoadjuvant Therapy for Resectable and Borderline Resectable Pancreatic Cancer: A Meta-Analysis of Randomized Controlled Trials
por: Cloyd, Jordan M., et al.
Publicado: (2020)

African Americans are less likely to receive curative treatment for hepatocellular carcinoma
por: Sobotka, Lindsay A, et al.
Publicado: (2018)

Cystoisospora belli Gallbladder Infection in a Liver Transplant Donor
por: Akateh, Clifford, et al.
Publicado: (2018)

Neoadjuvant therapy for resectable pancreatic ductal adenocarcinoma: The need for patient-centered research
por: Cloyd, Jordan M, et al.
Publicado: (2020)

Pretransplant Locoregional Therapy for Hepatocellular Carcinoma: Evaluation of Explant Pathology and Overall Survival
por: Beal, Eliza W., et al.
Publicado: (2016)

Current Landscape of Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma
por: Ruff, Samantha M., et al.
Publicado: (2023)

Impact of Recipient and Donor Obesity Match on the Outcomes of Liver Transplantation: All Matches Are Not Perfect
por: Beal, Eliza W., et al.
Publicado: (2016)

Characterizing the patient experience during neoadjuvant therapy for pancreatic ductal adenocarcinoma: A qualitative study
por: Stevens, Lena, et al.
Publicado: (2022)

Surgical Treatment of Intrahepatic Cholangiocarcinoma: Current and Emerging Principles
por: Beal, Eliza W., et al.
Publicado: (2020)

Adjuvant and Neoadjuvant Treatments for Resectable Hepatocellular Carcinoma
por: Crook, Christiana J., et al.
Publicado: (2023)

Locoregional Therapy Approaches for Hepatocellular Carcinoma: Recent Advances and Management Strategies
por: Makary, Mina S., et al.
Publicado: (2020)

Geographical differences exist in high‐value care delivery for inpatient management of cirrhosis: Cost conscious care in cirrhosis
por: Sobotka, Lindsay A, et al.
Publicado: (2018)

Impact of visitor restriction rules on the postoperative experience of COVID-19 negative patients undergoing surgery
por: Zeh, Ryan D., et al.
Publicado: (2020)

Neoadjuvant Immunotherapy for Localized Pancreatic Cancer: Challenges and Early Results
por: Chick, Robert Connor, et al.
Publicado: (2023)

Neoadjuvant‐modified FOLFIRINOX vs nab‐paclitaxel plus gemcitabine for borderline resectable or locally advanced pancreatic cancer patients who achieved surgical resection
por: Wolfe, Adam R., et al.
Publicado: (2020)

Update on Liver Failure Following Hepatic Resection: Strategies for Prediction and Avoidance of Post-operative Liver Insufficiency
por: Rahnemai-Azar, Amir A., et al.
Publicado: (2017)

Effect of transplant center volume on post-transplant survival in patients listed for simultaneous liver and kidney transplantation
por: Modi, Rohan M, et al.
Publicado: (2018)

Thirty-day readmission rates, trends and its impact on liver transplantation recipients: a national analysis
por: Mumtaz, Khalid, et al.
Publicado: (2020)

Disparities in Care Access to Liver-Directed Therapy Among Medicare Beneficiaries with Colorectal Cancer Liver Metastasis
por: Aquina, Christopher T., et al.
Publicado: (2022)

Neoadjuvant therapy for pancreatic ductal adenocarcinoma: Opportunities for personalized cancer care
por: Hamad, Ahmad, et al.
Publicado: (2021)

Real-World Use of Immunotherapy for Hepatocellular Carcinoma
por: Sara, Amir, et al.
Publicado: (2023)

Neoadjuvant treatment strategies for hepatocellular carcinoma
por: Xu, Lei, et al.
Publicado: (2021)

Comparing textbook outcomes among patients undergoing surgery for cancer at U. S. News & World Report ranked hospitals
por: Mehta, Rittal, et al.
Publicado: (2020)

Systemic Neoadjuvant and Adjuvant Therapies in the Management of Hepatocellular Carcinoma—A Narrative Review
por: Chamseddine, Shadi, et al.
Publicado: (2023)

Neoadjuvant and Adjuvant Chemotherapeutic Strategy of Colorectal Mixed Adeno-Neuroendocrine Carcinomas
por: Michael, Anita, et al.
Publicado: (2021)

Adjuvant and neoadjuvant therapies in melanoma
por: Lim, Kok Haw Jonathan, et al.
Publicado: (2020)

Social Vulnerability Subtheme Analysis Improves Perioperative Risk Stratification in Hepatopancreatic Surgery
por: Labiner, Hanna E., et al.
Publicado: (2022)

Novel Drug Candidate Prediction for Intrahepatic Cholangiocarcinoma via Hub Gene Network Analysis and Connectivity Mapping
por: Xiao, Yao, et al.
Publicado: (2022)

Burnout Assessment Among Surgeons and Surgical Trainees During the COVID-19 Pandemic: A Systematic Review
por: Shaikh, Chanza Fahim, et al.
Publicado: (2022)

Neoadjuvant and Adjuvant Therapy in Intrahepatic Cholangiocarcinoma
por: Chen, Xing, et al.
Publicado: (2022)

Neoadjuvant and adjuvant therapy in esophageal cancer
por: Weiss, Jennifer A., et al.
Publicado: (2023)

Current treatment of early breast cancer: adjuvant and neoadjuvant therapy
por: Miller, Elizabeth, et al.
Publicado: (2014)

Postoperative Adjuvant Treatment Strategy for Locally Advanced Rectal Cancer after Neoadjuvant Treatment
por: Li, Jia-yi, et al.
Publicado: (2021)

A review of the impact of obesity on common gastrointestinal malignancies
por: Krishna, Somashekar G., et al.
Publicado: (2017)

Advancements in Microwave Ablation Techniques for Managing Pancreatic Lesions
por: Ardeshna, Devarshi R., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_45hur4q723mtek2qikvc1c0qbd